Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pawel Hrycaj

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
The Journal of Rheumatology|January 1, 2003
Treatment resistant ankylosing spondylitis with peripheral joint involvement - a case for infliximab?Pawel Hrycaj, Jan K Lacki
Joint Bone Spine|October 18, 2003
Does infliximab decrease bone turnover in rheumatoid arthritis patientsIzabela Korczowska, Pawel Hrycaj, Jan K Lacki
Yonsei Medical Journal|December 11, 2012
Influence of infliximab on cytokines network and markers of bone remodeling in rheumatoid arthritis patientsIzabela Korczowska, Jan Krzysztof Lacki, Pawel Hrycaj
The Journal of Rheumatology|December 4, 2009
Fyn and CD70 expression in CD4+ T cells from patients with systemic lupus erythematosusAnna Kozlowska, Pawel Hrycaj, Jan K Lacki, et al.
International Orthopaedics|May 1, 2009
Large bone distractor for open reconstruction of articular fractures of the calcaneusPawel Grala, Wojciech Twardosz, Wieslaw Tondel, et al.
Clinical Rheumatology|September 23, 2020
Correction to: Efficacy and safety results from a randomized double-blind study comparing proposed biosimilar ABP 798 with rituximab reference product in subjects with moderate-to-severe rheumatoid arthritisGerd Burmester, Edit Drescher, Pawel Hrycaj, et al.
The Canadian Journal of Cardiology|January 25, 2007
Acute myocardial infarction and rapid development of coronary aneurysms in a young woman--unusual presentation of Takayasu arteritis?Aleksander Araszkiewicz, Marek Prech, Pawel Hrycaj, et al.
Clinical Rheumatology|September 3, 2020
Efficacy and safety results from a randomized double-blind study comparing proposed biosimilar ABP 798 with rituximab reference product in subjects with moderate-to-severe rheumatoid arthritisGerd Burmester, Edit Drescher, Pawel Hrycaj, et al.
Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University|August 7, 2018
The effect of caveolin-1 knockdown on interleukin-1β-induced chemokine (C-C motif) ligand 2 expression in synovial fluid-derived fibroblast-like synoviocytes from patients with rheumatoid arthritisDorota Trzybulska, Anna Olewicz-Gawlik, Jan Sikora, et al.
Connective Tissue Research|December 17, 2009
Blood serum levels of amino-terminal pro-C-type natriuretic peptide in patients with systemic sclerosisAnna Olewicz-Gawlik, Aleksandra Danczak-Pazdrowska, Kamilla Klama, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
The Journal of Rheumatology|January 1, 2003
Treatment resistant ankylosing spondylitis with peripheral joint involvement - a case for infliximab?Pawel Hrycaj, Jan K Lacki
Joint Bone Spine|October 18, 2003
Does infliximab decrease bone turnover in rheumatoid arthritis patientsIzabela Korczowska, Pawel Hrycaj, Jan K Lacki
Yonsei Medical Journal|December 11, 2012
Influence of infliximab on cytokines network and markers of bone remodeling in rheumatoid arthritis patientsIzabela Korczowska, Jan Krzysztof Lacki, Pawel Hrycaj
The Journal of Rheumatology|December 4, 2009
Fyn and CD70 expression in CD4+ T cells from patients with systemic lupus erythematosusAnna Kozlowska, Pawel Hrycaj, Jan K Lacki, et al.
International Orthopaedics|May 1, 2009
Large bone distractor for open reconstruction of articular fractures of the calcaneusPawel Grala, Wojciech Twardosz, Wieslaw Tondel, et al.
Clinical Rheumatology|September 23, 2020
Correction to: Efficacy and safety results from a randomized double-blind study comparing proposed biosimilar ABP 798 with rituximab reference product in subjects with moderate-to-severe rheumatoid arthritisGerd Burmester, Edit Drescher, Pawel Hrycaj, et al.
The Canadian Journal of Cardiology|January 25, 2007
Acute myocardial infarction and rapid development of coronary aneurysms in a young woman--unusual presentation of Takayasu arteritis?Aleksander Araszkiewicz, Marek Prech, Pawel Hrycaj, et al.
Clinical Rheumatology|September 3, 2020
Efficacy and safety results from a randomized double-blind study comparing proposed biosimilar ABP 798 with rituximab reference product in subjects with moderate-to-severe rheumatoid arthritisGerd Burmester, Edit Drescher, Pawel Hrycaj, et al.
Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University|August 7, 2018
The effect of caveolin-1 knockdown on interleukin-1β-induced chemokine (C-C motif) ligand 2 expression in synovial fluid-derived fibroblast-like synoviocytes from patients with rheumatoid arthritisDorota Trzybulska, Anna Olewicz-Gawlik, Jan Sikora, et al.
Connective Tissue Research|December 17, 2009
Blood serum levels of amino-terminal pro-C-type natriuretic peptide in patients with systemic sclerosisAnna Olewicz-Gawlik, Aleksandra Danczak-Pazdrowska, Kamilla Klama, et al.
Pageof 3